# Major Recall Alert: Skycare Compounding Laboratories Products Recalled Due to Products Sold Without Market Authorization (DINs) in Canada
Consumers need to be aware of a significant recall affecting a wide array of products sold by Skycare Compounding Laboratories in Canada. Health authorities have identified that these products, which include various IV drip solutions, topical creams, and wellness solutions, were sold without the required market authorization (DINs) in Canada. This poses potential safety concerns for consumers relying on these products for medical or health purposes.
Here’s what you need to know about this recall and how to take action!
## Why This Recall is Important
Market authorization is a mandatory process in Canada, monitored by Health Canada, to ensure the safety, efficacy, and quality of products intended for use by the public. Products sold without proper authorization have not undergone the necessary evaluations, putting users at potential risk.
Skycare Compounding Laboratories’ recalled products include several IV drip solutions and topical formulations touted for therapeutic and wellness benefits. Without a Drug Identification Number (DIN), consumers cannot be certain of the product’s composition, safety, or effectiveness.
The safety risks associated with unauthorized products may include:
- Adverse reactions to unknown or mislabeled ingredients
- Ineffective treatments leading to untreated medical conditions
- Potential contamination not detected due to insufficient regulatory testing
## Details of the Recall
The recall involves the following products manufactured and sold by **Skycare Compounding Laboratories** in Canada:
- **BiotinLixer 10 mL vial**
- **BlueThera 10 mg/mL solution**
- **Boost IV Drip solution**
- **Build IV Drip solution**
- **Glut Glow IV Drip solution**
- **Glutathione 200 mg/mL solution**
- **High C IV Drip solution**
- **M-UNE IV Drip solution**
- **MethylB12Pro solution**
- **NAD+ IV Drip solution**
- **NADcreation solution**
- **NRG IV Drip solution**
- **Paralisa+ Topical Crème** (jar and pump)
- **Phoslim solution**
- **Radiance IV Drip solution**
- **ShapeUp solution**
- **TripleDefense solution**
- **VitaGleam D3 solution**
Date of announcement: **October 2023**
Consumers who have purchased or used these products should stop use immediately and consult their healthcare provider if they experience any adverse effects.
For more details, refer to the **official Health Canada recall notice** [here](https://recalls-rappels.canada.ca/en/alert-recall/skycare-compounding-laboratories-products-recall-no-market-authorization).
## What You Should Do
If you have purchased or used the recalled products, follow these steps to protect yourself and others:
1. **Stop using the products immediately**, even if you haven’t experienced any negative side effects.
2. **Dispose of the products safely** following municipal waste guidelines or return them to the point of purchase if applicable.
3. **Contact a healthcare provider** if you have concerns about your health or experience symptoms after using these products.
4. Report any adverse health reactions caused by these products to Health Canada through the **Canada Vigilance Program**.
Help spread the word by notifying family and friends who might be affected by this recall.
## Stay Safe – Get Instant Recall Alerts
Keeping track of recalls can ultimately protect your health and well-being. Stay informed about product recalls like this one by downloading an app that provides instant notifications on recalls in Canada.
**Don’t miss critical safety updates! Download the free Recalls and Safety Alerts app today to get real-time notifications and protect yourself from potentially harmful products.**
For the latest updates and official recall notices, visit the [Health Canada Recall Page](https://recalls-rappels.canada.ca/en/alert-recall/skycare-compounding-laboratories-products-recall-no-market-authorization). Stay cautious, stay informed, and stay safe!